BETAGENE INC has a total of 20 patent applications. Its first patent ever was published in 1996. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are NEUROSPHERES HOLDINGS LTD, GENOVIE AB and AUSTRALIAN STEM CELL CT LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Agriculture | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Analysing materials | |
#4 | Peptides | |
#5 | Animal care | |
#6 | Therapeutic chemical compounds | |
#7 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Thigpen Anice E | 17 |
#2 | Clark Samuel A | 17 |
#3 | Quaade Christian | 13 |
#4 | Newgard Christopher B | 8 |
#5 | Kruse Fred | 7 |
#6 | Normington Karl D | 7 |
#7 | Halban Philippe A | 4 |
#8 | Mcgarry Dennis | 3 |
#9 | Becker Thomas C | 3 |
#10 | Halban Phillippe A | 2 |
Publication | Filing date | Title |
---|---|---|
AU1835801A | Recombinant expression of proteins from secretory cell lines | |
AU5931600A | Lcat recombinant cell line compositions and methods | |
AU4720500A | Recombinant expression of proteins from secretory cell lines | |
WO9935495A2 | Identification of substances that modify cellular secretory function | |
US6087129A | Recombinant expression of proteins from secretory cell lines | |
US5891717A | Methods and compositions for inhibiting hexokinase |